USPTO 2015–2025 USPTO PatentsView US Corporation

Belhaven BioPharma Inc.

USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Belhaven ranks #34,443 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.

#34,443
of 49,997 US assignees by volume
Top 22%
by Innovation Score (45.8/100)
19.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34443 · US Corporation #34,443 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 7 grants
  • MID-PACK #34,443/49,997
  • PHOTO-FINISH Beijing Netqin…
  • CPC-NARROW A61K · 4 areas
  • INNOV-PAR 45.8/100
  • CLAIMS-RICH 19.3 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Beijing Netqin Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Belhaven

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Belhaven's Innovation Score is 45.8/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Belhaven's grants concentrate

Belhaven BioPharma Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2022. By volume, Belhaven sits between Beijing Netqin Technology Co., Ltd. and Benbria Corporation.

Belhaven's three-year grant acceleration

Belhaven BioPharma Inc. shows 6 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Belhaven's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Belhaven holds 7 patents at rank #34,513, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Belhaven

By rank, the assignees closest to #34,513 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Belhaven's primary technology class.

Belhaven's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2022202320242025 1
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Belhaven BioPharma Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 1 14.3%
2023 1 14.3%
2024 4 57.1%
2025partial year 1 14.3%

Where it ranks

Overall rank by patents

#34,443

of 49,997 tracked assignees

Innovation Score

45.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Belhaven BioPharma Inc.'s patent record in context - here's where to go next.

  • Belhaven BioPharma Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #34,443 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Belhaven BioPharma Inc. against Beijing Netqin Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 45.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.